128 related articles for article (PubMed ID: 36067085)
1. Multicystic Biliary Hamartoma With Xanthogranulomatous Inflammation on 18F-FDG PET/CT.
Shono N; Otomi Y; Otsuka H; Shinya T; Harada M
Clin Nucl Med; 2022 Oct; 47(10):882-884. PubMed ID: 36067085
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the
Takahashi Y; Sato S; Ishitobi H; Nagaoka M; Kobayashi Y; Fukuhara H; Yuki M; Komazawa Y; Kuroda H; Shizuku T
Intern Med; 2017 Nov; 56(22):3027-3031. PubMed ID: 28943569
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Incidentally Discovered a Rare Cystic Lesion of Liver: Multicystic Biliary Hamartoma.
Mu W; Su P; Ning S
Pathol Oncol Res; 2021; 27():628323. PubMed ID: 34257591
[TBL] [Abstract][Full Text] [Related]
4. Multicystic biliary hamartoma with extremely elevated CA19-9: a case report.
Morinaga T; Imai K; Yamashita YI; Yamao T; Kaida T; Nakagawa S; Hashimoto D; Chikamoto A; Sumiyoshi S; Mikami Y; Baba H
Scand J Gastroenterol; 2017 Aug; 52(8):916-919. PubMed ID: 28485658
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study.
Hwang JP; Moon JH; Kim HK; Lee MH; Lim CH; Park SB; Yoon JK; Park JM
Medicine (Baltimore); 2021 May; 100(21):e26015. PubMed ID: 34032720
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma arising from preexisting biliary hamartoma of liver--report of a case.
Orii T; Ohkohchi N; Sasaki K; Satomi S; Watanabe M; Moriya T
Hepatogastroenterology; 2003; 50(50):333-6. PubMed ID: 12749215
[TBL] [Abstract][Full Text] [Related]
7. Multicystic biliary hamartoma mimicking intrahepatic cholangiocarcinoma: report of a case.
Yoh T; Okamura R; Nakayama H; Lin X; Nakamura Y; Kato T
Clin J Gastroenterol; 2014 Oct; 7(5):418-21. PubMed ID: 26184022
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholangiocarcinoma and portal hypertension developing in a patient with multicystic biliary microhamartomas.
Sugawara T; Shindoh J; Hoshi D; Hashimoto M
Malays J Pathol; 2018 Dec; 40(3):331-335. PubMed ID: 30580365
[TBL] [Abstract][Full Text] [Related]
9. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
Park MS; Lee SM
Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
[TBL] [Abstract][Full Text] [Related]
10. A Case of Multicystic Biliary Hamartoma with a Marked Peribiliary Gland Component Successfully Treated by Purely Laparoscopic Anatomical Liver Resection.
Kai K; Ide T; Tanaka T; Yukimoto K; Irie H; Noshiro H; Aishima S
J Gastrointest Cancer; 2023 Sep; 54(3):996-999. PubMed ID: 36449146
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
[TBL] [Abstract][Full Text] [Related]
12. Hamartoma of Mature Cardiac Myocytes Mimicking Malignancy on 18F-FDG PET/CT Images.
Jiang Y; Ma X; Tan Y; Lu Q; Wang Y
Clin Nucl Med; 2019 Nov; 44(11):892-894. PubMed ID: 31274563
[TBL] [Abstract][Full Text] [Related]
13. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
[TBL] [Abstract][Full Text] [Related]
14. Enhanced CT and FDG PET/CT findings of splenic hamartoma.
Dong A; Wang Y; Lu J; Zuo C
Clin Nucl Med; 2014 Nov; 39(11):968-71. PubMed ID: 24152626
[TBL] [Abstract][Full Text] [Related]
15. A variant of multicystic biliary hamartoma presenting as an intrahepatic cystic neoplasm.
Tominaga T; Abo T; Kinoshita N; Murakami T; Sato Y; Nakanuma Y; Harada K; Masuda J; Nagayasu T; Nanashima A
Clin J Gastroenterol; 2015 Jun; 8(3):162-6. PubMed ID: 26017582
[TBL] [Abstract][Full Text] [Related]
16. Multimodal imaging findings of intrahepatic cholangiocarcinoma arising from a biliary adenofibroma: a case report with radiological-pathological correlation.
Kanemaru N; Nakai Y; Watadani T; Nakao T; Hinata M; Nakazawa A; Akamatsu N; Ushiku T; Hasegawa K; Abe O
Abdom Radiol (NY); 2023 Aug; 48(8):2469-2476. PubMed ID: 37074475
[TBL] [Abstract][Full Text] [Related]
17. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
[TBL] [Abstract][Full Text] [Related]
18. Comparison of PET imaging of activated fibroblasts and
Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a biliary hamartoma with contrast-enhanced sonography using two different contrast agents.
Hohmann J; Loddenkemper C; Albrecht T
Ultraschall Med; 2009 Apr; 30(2):185-8. PubMed ID: 18726842
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
